Although high-dose aspirin can inhibit COX2, and COX2 signaling pathway is involved in the occurrence and angiogenesis of colorectal cancer [126], sustained inhibition of COX2 expression in tumor cells requires a higher dose (650 mg, 3–4 times/day) [127]. This evidence concerns the gene PTGS2 and colorectal cancer.